133 related articles for article (PubMed ID: 11795388)
1. An in vivo/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma.
Hodges LC; Hunter DS; Bergerson JS; Fuchs-Young R; Walker CL
Ann N Y Acad Sci; 2001 Dec; 948():100-11. PubMed ID: 11795388
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro.
Hodges LC; Bergerson JS; Hunter DS; Walker CL
Toxicol Sci; 2000 Apr; 54(2):355-64. PubMed ID: 10774817
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium.
Hunter DS; Hodges LC; Vonier PM; Fuchs-Young R; Gottardis MM; Walker CL
Cancer Res; 1999 Jul; 59(13):3090-9. PubMed ID: 10397250
[TBL] [Abstract][Full Text] [Related]
4. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.
Cook JD; Davis BJ; Goewey JA; Berry TD; Walker CL
Reprod Sci; 2007 Feb; 14(2):121-36. PubMed ID: 17636224
[TBL] [Abstract][Full Text] [Related]
5. Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids.
Hunter DS; Hodges LC; Eagon PK; Vonier PM; Fuchs-Young R; Bergerson JS; Walker CL
Environ Health Perspect; 2000 Oct; 108 Suppl 5():829-34. PubMed ID: 11035990
[TBL] [Abstract][Full Text] [Related]
6. Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.
Walker CL
Recent Prog Horm Res; 2002; 57():277-94. PubMed ID: 12017548
[TBL] [Abstract][Full Text] [Related]
7. Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol.
Greathouse KL; Cook JD; Lin K; Davis BJ; Berry TD; Bredfeldt TG; Walker CL
Reprod Sci; 2008 Oct; 15(8):765-78. PubMed ID: 19017814
[TBL] [Abstract][Full Text] [Related]
8. Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium.
Andersen J
Environ Health Perspect; 2000 Oct; 108 Suppl 5():811-5. PubMed ID: 11035987
[TBL] [Abstract][Full Text] [Related]
9. Invited comment: "Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats".
Segars JH
Reprod Sci; 2007 Feb; 14(2):99-100. PubMed ID: 17636221
[No Abstract] [Full Text] [Related]
10. Uterine leiomyomas: mechanisms of tumorigenesis.
Houston KD; Hunter DS; Hodges LC; Walker CL
Toxicol Pathol; 2001; 29(1):100-4. PubMed ID: 11215673
[TBL] [Abstract][Full Text] [Related]
11. An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells.
Gao X; Yu L; Castro L; Moore AB; Hermon T; Bortner C; Sifre M; Dixon D
Toxicol Lett; 2010 Jul; 196(3):133-41. PubMed ID: 20230880
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
13. [Xenoestrogens: endocrine disrupting compounds].
Wozniak M; Murias M
Ginekol Pol; 2008 Nov; 79(11):785-90. PubMed ID: 19140503
[TBL] [Abstract][Full Text] [Related]
14. A nongenomic mechanism for "metalloestrogenic" effects of cadmium in human uterine leiomyoma cells through G protein-coupled estrogen receptor.
Liu J; Yu L; Castro L; Yan Y; Sifre MI; Bortner CD; Dixon D
Arch Toxicol; 2019 Oct; 93(10):2773-2785. PubMed ID: 31468104
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.
Fuchs-Young R; Howe S; Hale L; Miles R; Walker C
Mol Carcinog; 1996 Nov; 17(3):151-9. PubMed ID: 8944075
[TBL] [Abstract][Full Text] [Related]
16. Relationship between in vitro relaxation of the costo-uterine smooth muscle and mesovarial leiomyoma formation in vivo by beta-receptor agonists.
Colbert WE; Wilson BF; Williams PD; Williams GD
Arch Toxicol; 1991; 65(7):575-9. PubMed ID: 1685881
[TBL] [Abstract][Full Text] [Related]
17. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
18. Xenoestrogens: mechanisms of action and some detection studies.
Słomczyńska M
Pol J Vet Sci; 2008; 11(3):263-9. PubMed ID: 18942551
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors in leiomyomas and normal uterine tissues during reproductive life.
Marelli G; Codegoni AM; Bizzi A
Acta Eur Fertil; 1989; 20(1):19-22. PubMed ID: 2781983
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of Wnt7a mRNA is inversely associated with the expression of estrogen receptor-alpha in human uterine leiomyoma.
Li S; Chiang TC; Davis GR; Williams RM; Wilson VP; McLachlan JA
J Clin Endocrinol Metab; 2001 Jan; 86(1):454-7. PubMed ID: 11232041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
